Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Jul;39(7):1565–1568. doi: 10.1128/aac.39.7.1565

In vitro and in vivo effects of penicillin and clindamycin on expression of group A beta-hemolytic streptococcal capsule.

I Brook 1, A E Gober 1, F Leyva 1
PMCID: PMC162782  PMID: 7492105

Abstract

Encapsulation of group A beta-hemolytic streptococci (GABHS) is an important virulence factor. The changes that occur in the frequency of encapsulation of GABHS during pharyngotonsillitis, in 20 patients treated with penicillin and 20 treated with clindamycin, were investigated. The effects of subinhibitory concentrations of these agents were also evaluated in vitro. At day 4, 8 of 10 (80%) GABHS isolates recovered from children treated with penicillin were encapsulated, compared with 1 of 5 (20%) of those from children treated with clindamycin (P < 0.05). Two days following 10 days of therapy, GABHS was eliminated from 13 of the 20 (65%) children treated with penicillin and from all treated with clindamycin (P < 0.05). At that time, six of the seven GABHS isolates recovered in patients treated with penicillin were encapsulated. GABHS were not detected after 4 days of therapy in those treated with clindamycin. Incubation of GABHS isolates with one-half of the MIC of clindamycin reduced the frequency of encapsulation, compared with that after incubation with one-half of the MIC of penicillin (12.5 versus 67.5%). These data illustrate the superiority of clindamycin over penicillin in reducing the expression of a capsule by GABHS.

Full Text

The Full Text of this article is available as a PDF (673.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brook I., Gober A. E. Bacteroides melaninogenicus. Its recovery from tonsils of children with acute tonsillitis. Arch Otolaryngol. 1983 Dec;109(12):818–820. doi: 10.1001/archotol.1983.00800260040010. [DOI] [PubMed] [Google Scholar]
  2. Brook I., Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin, and clindamycin. Clin Pediatr (Phila) 1985 Jun;24(6):331–336. doi: 10.1177/000992288502400606. [DOI] [PubMed] [Google Scholar]
  3. Brook I., Myhal L. A., Dorsey C. H. Encapsulation and pilus formation of Bacteroides spp. in normal flora abscesses and blood. J Infect. 1992 Nov;25(3):251–257. doi: 10.1016/0163-4453(92)91479-u. [DOI] [PubMed] [Google Scholar]
  4. Brook I., Yokum P. In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis. Chemotherapy. 1983;29(1):18–23. doi: 10.1159/000238168. [DOI] [PubMed] [Google Scholar]
  5. FOLEY M. J., WOOD W. B., Jr Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. J Exp Med. 1959 Oct 1;110:617–628. doi: 10.1084/jem.110.4.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gemmell C. G., Peterson P. K., Schmeling D., Kim Y., Mathews J., Wannamaker L., Quie P. G. Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin. J Clin Invest. 1981 May;67(5):1249–1256. doi: 10.1172/JCI110152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kasper D. L. Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis. 1976 Jul;134(1):59–66. doi: 10.1093/infdis/134.1.59. [DOI] [PubMed] [Google Scholar]
  8. Milatovic D., Braveny I., Verhoef J. Clindamycin enhances opsonization of Staphylococcus aureus. Antimicrob Agents Chemother. 1983 Sep;24(3):413–417. doi: 10.1128/aac.24.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stillerman M., Isenberg H. D., Facklam R. R. Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrob Agents Chemother. 1973 Nov;4(5):514–520. doi: 10.1128/aac.4.5.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tanz R. R., Poncher J. R., Corydon K. E., Kabat K., Yogev R., Shulman S. T. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci. J Pediatr. 1991 Jul;119(1 Pt 1):123–128. doi: 10.1016/s0022-3476(05)81052-2. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES